| PERIOD ENDING | 31-Dec-08 | | Total Revenue | 226,436 | | Cost of Revenue | 153,669 | | | Gross Profit | 72,767 | | | Operating Expenses | | Research Development |
-
| | Selling General and Administrative | 55,395 | | Non Recurring | 59,838 | | Others | 1,336 | | | | Total Operating Expenses |
-
| | | | Operating Income or Loss | (43,802) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (132) | | Earnings Before Interest And Taxes | (43,934) | | Interest Expense | 40,286 | | Income Before Tax | (84,220) | | Income Tax Expense | 721 | | Minority Interest | 26,534 | | | | Net Income From Continuing Ops | (58,407) | | | Non-recurring Events | | Discontinued Operations |
-
| | Extraordinary Items |
-
| | Effect Of Accounting Changes |
-
| | Other Items |
-
| | | | Net Income | (58,407) | | Preferred Stock And Other Adjustments |
-
| | | Net Income Applicable To Common Shares | ($58,407) |
|
1.52% Nasdaq 
Income Statement
